GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CG Oncology Inc (NAS:CGON) » Definitions » Net Income (Discontinued Operations)

CGON (CG Oncology) Net Income (Discontinued Operations) : $0.00 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is CG Oncology Net Income (Discontinued Operations)?

Net Income (Discontinued Operations) indicates the net income that a firm brought in from operations that will not be used in future reporting periods. CG Oncology's Net Income (Discontinued Operations) for the three months ended in Mar. 2025 was $0.00 Mil. Its Net Income (Discontinued Operations) for the trailing twelve months (TTM) ended in Mar. 2025 was $0.00 Mil.

CG Oncology Net Income (Discontinued Operations) Historical Data

The historical data trend for CG Oncology's Net Income (Discontinued Operations) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CG Oncology Net Income (Discontinued Operations) Chart

CG Oncology Annual Data
Trend Dec21 Dec22 Dec23 Dec24
Net Income (Discontinued Operations)
- - - -

CG Oncology Quarterly Data
Dec21 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Net Income (Discontinued Operations) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only - - - - -

CG Oncology Net Income (Discontinued Operations) Calculation

Net Income (Discontinued Operations) indicates the net income that a firm brought in from operations that will not be used in future reporting periods.

Net Income (Discontinued Operations) for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

CG Oncology Net Income (Discontinued Operations) Related Terms

Thank you for viewing the detailed overview of CG Oncology's Net Income (Discontinued Operations) provided by GuruFocus.com. Please click on the following links to see related term pages.

CG Oncology Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CG Oncology Inc (NAS:CGON) » Definitions » Net Income (Discontinued Operations)
Comparable Companies
DNLI KYMR LGND HRMY FOLD NAMS VCEL TARS ARWR AGIO VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX
Traded in Other Exchanges
N/A
Address
400 Spectrum Center Drive, Suite 2040, Irvine, CA, USA, 92618
Website
https://www.cgoncology.com
CG Oncology Inc is a late-stage clinical biopharmaceutical company focused on developing and commercializing a potential backbone bladder-sparing therapeutic for patients afflicted with bladder cancer. The company's lead candidate, cretostimogene grenadenorepvec, is a targeted oncolytic intravesically delivered immunotherapy agent that is in two phase three trials (one high-risk BCG unresponsive NMIBC trial and one intermediate-risk NMIBC trial) and a phase two clinical study with a checkpoint inhibitor for high-risk BCG unresponsive NMIBC disease.